{
    "code": "01037537",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01037537",
    "time": "2016-10-21 03:26:53",
    "許可證字號": "衛署藥製字第037537號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/09\/08",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "103\/04\/20",
    "發證日期": "86\/04\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103753707",
    "中文品名": "&quot;中國化學＂庇邁痛注射液30公絲\/公攝（實菲那特林）",
    "英文品名": "ORNALEX INJECTION 30MG\/ML (ORPHENADRINE) &quot;C.C.P.C.&quot;",
    "適應症": "肌肉僵硬、疼痛、扭傷、局部肌肉損傷、椎間盤脫臼、腰背痛、纖維織炎、非關節性風濕炎、骨折、外科手術後焦慮、緊張。",
    "劑型": "270注射劑",
    "包裝": "2ML安瓿 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "ORPHENADRINECITRATE"
    ],
    "限制項目": "01國　產 1G不得製造",
    "申請商名稱": "0402606200  中國化學製藥股份有限公司新豐工廠",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0402602400  中國化學製藥股份有限公司樹林工廠",
        "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003420",
            "成分名稱": "ORPHENADRINE CITRATE",
            "含量描述": "30",
            "含量": "30.0000000000",
            "單位": "MG"
        }
    ]
}